Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Drug-induced Bullous Pemphigoid and Lupus Erythematosus Occurring under Anti-TNF-α and IL-6 Therapy in a Patient with Rheumatoid Arthritis

Published:2020-10-15 Issue:20 Volume:59 Page:2611-2618
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yoshikawa Noritada¹²,Matsubara Erika¹,Yamamoto Motohisa¹²,Yamazaki Hiroki¹,Uehara Masaaki¹,Kamata Masahiro³,Tanaka Hirotoshi¹²

Affiliation:

1. Department of Rheumatology and Allergy, IMSUT Hospital, Institute of Medical Science, The University of Tokyo, Japan

2. Division of Rheumatology, Center for Antibody and Vaccine Therap, IMSUT Hospital, Institute of Medical Science, The University of Tokyo, Japan

3. Department of Dermatology, Teikyo University School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/20/59_4646-20/_pdf

Reference47 articles.

1. 1. Jani M, Dixon WG, Chinoy H. Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far. Rheumatology (Oxford) 57: 1896-1907, 2018.

2. 2. Winthrop KL, Weinblatt ME, Crow MK, et al. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Ann Rheum Dis 78: 872-878, 2019.

3. 3. He Y, Sawalha AH. Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr Opin Rheumatol 30: 490-497, 2018.

4. 4. Schmidt E, Zillikens D. Pemphigoid diseases. Lancet 381: 320-332, 2013.

5. 5. Vassileva S, Drenovska K, Manuelyan K. Autoimmune blistering dermatoses as systemic diseases. Clin Dermatol 32: 364-375, 2014.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07

2. Dramatic deterioration or new‐onset dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid after COVID‐19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome;JEADV Clinical Practice;2023-04-17

3. Paradoxical phenomena of bullous pemphigoid induced and treated by identical biologics;Frontiers in Immunology;2023-01-05

4. The significance of preclinical anti-BP180 autoantibodies;Frontiers in Immunology;2022-08-08

5. TNF-Induced Lupus. A Case-Based Review;Current Rheumatology Reviews;2021-11-02